Viewing Study NCT01461057


Ignite Creation Date: 2025-12-24 @ 6:45 PM
Ignite Modification Date: 2025-12-31 @ 2:31 AM
Study NCT ID: NCT01461057
Status: COMPLETED
Last Update Posted: 2018-08-09
First Post: 2011-10-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer
Sponsor: Hoffmann-La Roche
Organization: